MRSN Financials

Mersana Therapeutics Inc - Financial statements & key metrics

Stock Price

$0.00

Market Cap

$145.36M

EPS

$-13.95

Income Statement Highlights

Most Recent Quarter: 2024-12-31

Revenue

$40.50M

Gross Profit

Operating Income

Net Income

$-69.19M

EPS (Diluted)

$-0.56

Balance Sheet Highlights

Total Assets

$144.66M

Total Liabilities

$154.17M

Shareholders Equity

Cash & Equivalents

$107.75M

Total Debt

Profitability Metrics

Operating Margin

-67.9%

Net Margin

-211.2%

ROE

-505.1%

View Complete Financial Statements

Full income statements, balance sheets, and cash flows for multiple periods

Open Full Financials

Frequently Asked Questions

What is MRSN revenue?

MRSN's most recent quarterly revenue was $40.50M. Annual revenue can be calculated by summing the four most recent quarters.

Is MRSN profitable?

MRSN reported a loss of $69.19M in the most recent quarter. The net profit margin is -211.2%.

What is MRSN market cap?

MRSN has a market capitalization of $145.36M, making it a small-cap stock.

Does MRSN have debt?

View MRSN's balance sheet for debt information.

What is MRSN cash flow?

Cash flow data is available in the full financial statements.